GlassScriptPhysician profile
Heather A Derrick
NPI 1407050099
$5,081.25
in general payments reported to CMS, 2019-2025
51 companies · $233 in 2025
The $233 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $671 · 2020: $473 · 2021: $1,348 · 2022: $800 · 2023: $1,017 · 2024: $540 · 2025: $233.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,705 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,704.93 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $722.04 | 2019-2024 | Lo Loestrin Fe |
| Daiichi Sankyo INC. | $361.26 | 2019-2023 | Injectafer |
| Astellas Pharma US INC | $334.34 | 2019-2025 | Veozah, Myrbetriq |
| Pfizer INC. | $292.05 | 2021-2024 | |
| Mayne Pharma Commercial LLC | $246.33 | 2021-2023 | |
| Hologic Sales and Service, LLC | $201.45 | 2019-2025 | Aptima, Thinprep 2000 Processor, Novasure |
| Organon LLC | $196.99 | 2021-2025 | Nexplanon |
| Exeltis, USA INC. | $192.24 | 2020-2024 | Slynd |
| Biohaven Pharmaceuticals, INC. | $191.14 | 2020-2021 | |
| Duchesnay USA Incorporated | $185.78 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $174.47 | 2019-2024 | |
| Agile Therapeutics, INC. | $160.58 | 2021-2024 | Twirla |
| Millicent US INC | $159.13 | 2019-2024 | Intrarosa, Femring |
| Therapeuticsmd, INC. | $128.11 | 2019-2021 | |
| Lupin INC. | $116.37 | 2019-2021 |
Show all 50 companies
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$5.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Derrick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.